? ? Our aim is to train MD's and MD-PhD's who have completed a clinical neuroscience residency and train them in:(1) the clinical, pathophysiologic, and pharmacologic aspects of neurologic diseases;(2) the conceptualization, ethics, design, implementation, management, analysis and reporting of controlled clinical trials; and (3)methodologies for population-based clinical research, including biostatistics and epidemiology. These goals are achieved by an integrated 2-3 year program that provides:(1)preceptorial supervision by neuroscientists and biostatisticians who have extensive experience in clinical investigation and in the development of novel therapies;(2}a customized curriculum of basic and applied statistics, neuroepidemiology and computer science;(3)seminar programs on clinical trial design; the basic sciences underlying experimental therapeutics; neuroethics; and grant and career development; (4)participation and collaboration with faculty from Neurology and Preventive & Community Medicine with expertise in outcome costeffectiveness, quality of life and other areas of health service research;(5) clinical experience in disease states under intensive investigation in Rochester and;(6)mentoring to assist trainees in achieving an independent academic career. Training draws on the strengths of:(1) clinical neuroscientists with investigative programs in neuromuscular disease, movement disorders, multiple sclerosis, dementia, epilepsy, stroke, and AIDS;{2) substantive collaboration with faculty in the Biostatistics Department;(3) formalized teaching and research interactions with basic neuroscientists and;(4)the comprehensive resources of the Clinical Trials Coordination Centers in the Department of Neurology. The goal is to provide the trainee with the skills necessary to:(1) generate new therapeutic knowledge applicable to neurologic disorders;(2) achieve independent professional growth and funding. and (3) obtain a tenure-track faculty position in a subspecialty of clinical neuroscience. The program is in its 14th year and has trained 27 neurologists, 2 neuropsychologists, 1 neonatologist, 1 PhD biostatistician, 1 neurosurgeon, and 2 leaders in the pharmaceutical industry. Graduates include 1 professor of neurology, 6 assoc professors of neurology,15 assist professors of neurology, 1 assistant professor of pediatrics, and 1 associate professor of biostatistics. All are pursuing clinical neuroscience investigations and are supported by over 76 investigator-initiated research grants and have authored over 380 peer-reviewed research papers. Support is sought for 4 post-residency trainees, accepting 2-4 trainees yearly into the program. Minority recruitment is emphasized. Training facilities include: the General Clinical Research Center, Clinical Trials Coordination Centers, Biostatistics Department, Gorell Molecular Biology Laboratory, Center for Aging & Developmental Biology. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Institutional National Research Service Award (T32)
Project #
2T32NS007338-16
Application #
6894371
Study Section
Special Emphasis Panel (ZNS1-SRB-M (15))
Program Officer
Korn, Stephen J
Project Start
1990-07-01
Project End
2010-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
16
Fiscal Year
2005
Total Cost
$266,097
Indirect Cost
Name
University of Rochester
Department
Neurology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Johnson, Nicholas E; Kaloides, Amy; Jones, Elaine (2016) Neurology Advocacy 2.0: After Sustainable Growth Rate Repeal. JAMA Neurol 73:151-2
Heatwole, Chad; Bode, Rita; Johnson, Nicholas E et al. (2016) Myotonic dystrophy health index: Correlations with clinical tests and patient function. Muscle Nerve 53:183-90
Salinas, Joel; Sprinkhuizen, Sara M; Ackerson, Teri et al. (2016) An International Standard Set of Patient-Centered Outcome Measures After Stroke. Stroke 47:180-6
Johnson, Nicholas E; Ekstrom, Anne-Berit; Campbell, Craig et al. (2016) Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy. Dev Med Child Neurol 58:698-705
Bednasz, Cindy; Luque, Amneris E; Zingman, Barry S et al. (2016) Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. Curr Vasc Pharmacol 14:280-7
Bellizzi, Matthew J; Geathers, Jasmine S; Allan, Kevin C et al. (2016) Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis. J Neurosci 36:1336-46
Rowe, Ian A; Tully, Damien C; Armstrong, Matthew J et al. (2016) Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation. Liver Transpl 22:287-97
Statland, Jeffrey M; Heatwole, Chad; Eichinger, Katy et al. (2016) Electrical impedance myography in facioscapulohumeral muscular dystrophy. Muscle Nerve 54:696-701
Damania, D; Kung, N T-M; Jain, M et al. (2016) Factors associated with recurrent stroke and recanalization in patients presenting with isolated symptomatic carotid occlusion. Eur J Neurol 23:127-32
Tawil, Rabi; Kissel, John T; Heatwole, Chad et al. (2015) Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Is Neurology 85:357-64

Showing the most recent 10 out of 77 publications